C. Arnoulet

发表

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

D. Olive, D. Blaise, A. Toubert, 2017, Oncoimmunology.

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

Daniel Olive, D. Olive, C. Fauriat, 2007, Blood.

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome.

F. Puppo, B. Esterni, J. Borg, 2010, Blood.

A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand

D. Olive, C. Arnoulet, F. Mallet, 2002, Leukemia.

Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targets

D. Olive, H. Chambost, C. Arnoulet, 2000, Leukemia.

Detection of Epithelial Cells in Hematopoietic Organs of Patients with Breast Cancer

P. Viens, C. Arnoulet, C. Chabannon, 2001, Acta Haematologica.

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia

S. Granjeaud, D. Olive, D. Blaise, 2015, Front. Immunol..

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

D. Birnbaum, V. Trouplin, N. Aceto, 2008, BMC Cancer.

Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method

F. Jardin, F. Durrieu, S. Leprêtre, 2008, Haematologica.

A myeloproliferative disorder may hide another one.

C. Arnoulet, M. Mozziconacci, D. Sainty, 2009, Leukemia research.

Reduced‐intensity conditioning allogeneic stem cell transplantation for patients with chemoresistant or relapsed follicular lymphoma

R. Bouabdallah, L. Xerri, D. Blaise, 2006, British journal of haematology.

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

D. Birnbaum, C. Arnoulet, N. Vey, 2015, Blood Cancer Journal.

Improved outcome of patients with low‐ and intermediate‐risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine

B. Esterni, D. Blaise, R. Devillier, 2011, Cancer.

Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy.

J. Gabert, C. Arnoulet, D. Maraninchi, 1995, Leukemia & lymphoma.

Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy

F. Bertucci, P. Viens, C. Arnoulet, 2003, Bone Marrow Transplantation.

Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010.

F. Lacombe, M. Béné, É. Lainey, 2011, Immunology letters.

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

D. Birnbaum, R. Devillier, J. Rey, 2014, Haematologica.

Clinical and biologic features of CD4(+)CD56(+) malignancies.

B. Drénou, M. Béné, R. Gressin, 2002, Blood.

Detection of CBFβ/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics

J. Gabert, P. Lécine, J. Imbert, 1997, Leukemia.

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

D. Birnbaum, P. Finetti, B. Esterni, 2010, British journal of haematology.

Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction

D. Blaise, J. Rey, C. Arnoulet, 2012, Leukemia & lymphoma.

Erratum to “Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia” [Hum Pathol 2008;39:1050-1058]

L. Xerri, B. Chetaille, D. Olive, 2010 .

Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report

D. Olive, D. Blaise, M. Mohty, 2001, Bone Marrow Transplantation.

True histiocytic lymphoma following B‐acute lymphoblastic leukaemia: case report with evidence for a common clonal origin in both neoplasms

R. Bouabdallah, L. Xerri, B. Chetaille, 2001, British journal of haematology.

t(4;12)(q11;p13) in a CD7-negative acute myeloid leukaemia.

C. Arnoulet, M. Lafage‐Pochitaloff, E. Garnotel, 1997, British journal of haematology.

Minor breakpoint cluster region (m‐BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report

R. Bouabdallah, J. Gabert, C. Arnoulet, 1995, British journal of haematology.

Direct evidence for dissociated megakaryocytic chimaerism in a Wiskott‐Aldrich patient successfully allografted

D. Blaise, C. Arnoulet, D. Maraninchi, 1995, British journal of haematology.

Prognostic value of multicenter flow cytometry harmonized assessment of minimal residual disease in acute myeloblastic leukemia

H. Dombret, A. Baruchel, F. Lacombe, 2018, Hematological oncology.

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

O. Casasnovas, F. Lacombe, M. Béné, 2009, Leukemia.

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms

F. Bertucci, D. Birnbaum, P. Finetti, 2012, Genes, chromosomes & cancer.

Philadelphia chromosome‐negative chronic myeloid leukaemia: a report of 14 new cases

R. Bouabdallah, J. Gabert, C. Arnoulet, 1995, British journal of haematology.

Cytogénétique Hématologique (GFCH) d'Hématologie Cellulaire (GFHC) and the Groupe Français de gene mutations: a report of 59 cases by the Groupe Français M0 AML, clinical and biologic features of the disease, includingAML1

O. Casasnovas, E. Macintyre, R. Berger, 2013 .

Brief report M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Franc¸ais d’He´matologie Cellulaire (GFHC) and the Groupe Franc¸ais de Cytoge´ne´tique He´matologique (GFCH)

O. Casasnovas, E. Macintyre, R. Berger, 2003 .

Concomitant germ‐line RUNX1 and acquired ASXL1 mutations in a T‐cell acute lymphoblastic leukemia

D. Birnbaum, W. Vainchenker, R. Favier, 2013, European journal of haematology.

Tumor cells in breast tumors: significance of their presence for prognosis

C. Arnoulet, J. Lotz, D. Sainty, 1999 .

Recovery of Lymphocyte and Dendritic Cell Subsets Following Reduced Intensity Allogeneic Bone Marrow Transplantation

R. Bouabdallah, D. Olive, D. Blaise, 2002, Hematology.

Normal levels of peripheral CD19+CD5+ CLL‐like cells: Toward a defined threshold for CLL follow‐up—A GEIL‐GOELAMS study

P. Feugier, F. Durrieu, M. Béné, 2011, Cytometry. Part B, Clinical cytometry.

Acute Megakaryoblastic Leukaemia: A National Clinical and Biological Study of 53 Adult and Childhood Cases by the Groupe Français d'Hématologie Cellulaire (GFHC)

G. Flandrin, C. Arnoulet, N. Dastugue, 2003, Leukemia & lymphoma.

Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia

F. Birg, J. Gabert, L. Coignet, 1995, Genes, chromosomes & cancer.

All‐trans retinoic acid skews monocyte differentiationinto interleukin‐12‐secreting dendritic‐like cells

D. Olive, M. Mohty, D. Isnardon, 2003, British journal of haematology.

Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level

R. Bouabdallah, D. Blaise, M. Mohty, 2004, Transfusion.

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.

D. Birnbaum, L. Kanz, C. Hannum, 1996, Leukemia.

Four‐ and five‐color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: A reference document based on a systematic approach by the GTLLF and GEIL

Jean Feuillard, Francis Lacombe, Bernard Husson, 2009, Cytometry. Part B, Clinical cytometry.

Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.

L. Xerri, B. Chetaille, D. Olive, 2008, Human pathology.

Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.

R. Bouabdallah, J. Gabert, L. Coignet, 1995, Cancer genetics and cytogenetics.

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice.

D. Birnbaum, L. Xerri, B. Delaval, 2004, Blood.

Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classification

C. Schiff, J. Gabert, B. Lemmers, 2000, Leukemia.

Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion.

D. Birnbaum, L. Xerri, B. Delaval, 2005, International journal of oncology.

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

D. Birnbaum, C. Récher, C. Demur, 2015, Oncotarget.

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

R. Bouabdallah, B. Esterni, D. Blaise, 2005, Bone Marrow Transplantation.

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

D. Olive, D. Blaise, M. Mohty, 2002, Leukemia.

A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.

R. Naumann, C. Arnoulet, G. Ehninger, 2001, Clinical and laboratory haematology.

Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration

C. Arnoulet, N. Vey, D. Sainty, 1996, British journal of haematology.

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

S. Granjeaud, D. Olive, A. Toubert, 2017, Front. Immunol..

Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.

D. Olive, C. Arnoulet, F. Mallet, 2000, Cancer research.

Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling

E. Devilard, F. Bertucci, C. Nguyen, 2004, Oncogene.

In vitro response to all‐trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes

F. Birg, P. Pelicci, C. Arnoulet, 1998, Genes, chromosomes & cancer.

Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia

B. Esterni, D. Coso, C. Arnoulet, 2007, Cancer.

Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience

F. Massin, A. Plesa, F. Garnache-Ottou, 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38− leukemic progenitors

D. Olive, H. Chambost, C. Arnoulet, 1999, Leukemia.

A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusion.

D. Birnbaum, C. Arnoulet, A. Murati, 2003, International journal of molecular medicine.

Clinical and biologic features of CD 4 1 CD 56 1 malignancies

B. Drénou, M. Béné, R. Gressin, 2002 .

Trisomy 11 in acute myeloid leukemia: ten cases.

C. Arnoulet, G. Marit, N. Dastugue, 1994, Leukemia.

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.

F. Birg, A. Hagemeijer, S. Fenu, 2000, Blood.

leukemia distinguishes cases with underlying A new morphologic classification system for acute promyelocytic

Marina, F. Birg, A. Hagemeijer, 2000 .

Presence of a minor Philadelphia-positive clone in young adults with de novo T-cell ALL

D. Blaise, D. Coso, C. Arnoulet, 2009, Leukemia & lymphoma.

Deactivation of alveolar macrophages in septic neutropenic ARDS.

J. Blache, R. Bouabdallah, J. Mege, 2003, Chest.

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH).

O. Casasnovas, E. Macintyre, R. Berger, 2003, Blood.

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F. Jardin, T. Petrella, E. Macintyre, 2019, Blood advances.

Immune reconstitution after blood cell transplantation.

D. Blaise, C. Arnoulet, C. Chabannon, 1997, Hematology and cell therapy.

The Philadelphia chromosome as a secondary abnormality in two cases of acute myeloid leukemia

A. Hagemeijer, J. Gabert, C. Arnoulet, 1998, British journal of haematology.

Evaluation of comorbidity indexes in the outcome of elderly patients treated for acute lymphoblastic leukemia

D. Blaise, J. Rey, C. Arnoulet, 2014, Leukemia & lymphoma.

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

S. Granjeaud, D. Olive, A. Cerwenka, 2017, Oncotarget.

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

F. Jardin, E. Macintyre, B. Drénou, 2015 .

Plasmodium falciparum Malaria Infection Complicated by Haemophagocytic Syndrome in an Old Man

F. Retornaz, C. Arnoulet, D. Sainty, 2000, Acta Haematologica.

F. Bertucci, D. Birnbaum, P. Finetti, 2013, Haematologica.

Identification of a myeloma variant with aggressive biological and clinical characteristics: “Early” plasma cell meningitis

R. Bouabdallah, J. Azulay, C. Arnoulet, 1997, American journal of hematology.

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

D. Birnbaum, V. Trouplin, N. Aceto, 2008, BMC Cancer.

HLA-DR and B7-2 (CD86) monocyte expressions after major cancer surgery: profile in sepsis.

J. Blache, C. Arnoulet, M. Leone, 2011, Minerva anestesiologica.

Improved outcome of patients with low‐ and intermediate‐risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine

B. Esterni, D. Blaise, R. Devillier, 2011, Cancer.

Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-doses of cyclophosphamide.

J. Blache, D. Blaise, P. Viens, 1999, International journal of oncology.